List of members:
Mr. Øyvin A. Brøymer, Chairman
Øyvin Brøymer has served as Chair of Medistim since 2000. He works as an investor through his own company Intertrade Shipping AS and holds the position of Chair in Vistin Pharma ASA. Previous experience includes executive positions in The Aker Group, Hafslund Nycomed ASA, and Leif Höegh & Co ASA, as well as broad boardroom experience from many other companies. Mr. Brøymer holds a business degree from the Norwegian School of Management and an MBA from the University of Wisconsin. He is also Chair of the remuneration committee. His term expires in 2025.
Ms. Anna Ahlberg, Board Member
Anna Ahlberg is the CFO at the Swedish medical simulation company Surgical Science. Her previous career includes executive positions at several listed Swedish companies, such as med-tech companies Q-Med and Vitrolife. Ms. Ahlberg holds an MSc in Business Administration and Economics from the School of Business, Economics and Law, University of Gothenburg. She is an independent Board member and is a member of the audit committee. Her term expires in 2025.
Ms. Anthea Arff-Pettersen, Board Member
Anthea Arff-Pettersen is a Partner and Investment Director at Aeternum Capital. Her previous experiences are from Schroders and M&G investments in London, private equity firm Credo Partners in Oslo, and Höegh Autoliners in New York. Ms. Arff-Pettersen holds an MSc in Investment Management from Cass Business School and a BSc in Business Administration from the University of Bath. She is a member of the audit committee. Her term expires in 2024.
Mr. Ole J. Dahlberg, Board Member
Ole Dahlberg is CEO at Curida, a life science company that develops and manufactures medicines, ensuring a safe supply of life-improving products. He has been in executive leadership roles both on the commercial side and in R&D at Dynal Biotech, German Biotech company Qiagen, and more recently for Thermo Fisher Scientific in the US. Mr. Dahlberg holds an MSc in Genetics and Marine Biology from the University of Oslo. His term expires in 2025.
Mr. Jon H. Hoem, Board Member
Jon Hoem was one of the early employees at Medistim, joining the company in 1994, and contributing to structuring Medistim’s initial sales effort in Europe, Japan, and the United States. He has founded multiple early-stage cardiovascular medical device companies. Mr. Hoem holds an MSc degree in microelectronics and organizational development from the Norwegian Institute of Technology (NTNU). His term expires in 2024.
Mr. Lars Rønn, Board Member
Lars Rønn has been a board member of Medistim since 2010. He is a consultant for Korn Ferry Associates, focusing on recruitment of executives within the med-tech area. He has previous executive experience from Ambu, Origio, and Maersk-Medical AS. Mr. Rønn holds a BSc in Business, Language & Culture and has a Graduate Diploma in Int. Trade from Copenhagen Business School. He also has a Management Program from INSEAD. He is an independent board member and is a member of the remuneration committee. His term expires 2024.
Ms. Tove Raanes, Board Member
Tove Raanes has been a board member of Medistim since 2014. She is an advisor in the investment companies Dyvi Invest AS and Nore-Invest AS and serves as a board member in Bouvet ASA, Multiconsult ASA, and Krefting AS. Her experience includes strategy, finance, and business development from investment companies and management consulting from McKinsey & Company. Ms. Raanes holds a MSc from the Norwegian School of Economics (NHH). She is an independent board member and is Chair of the audit committee. Her term expires 2024.